Qingqi Chen

Angestellt, Manager, Biosciences Inc

Chapel Hill, Vereinigte Staaten

Fähigkeiten und Kenntnisse

a comprehensive collection of anticancer molecular
which included all worldwide approved anticancer d
anticancer drug candidates which is currently unde
and anticancer drug candidates which is currently

Werdegang

Berufserfahrung von Qingqi Chen

  • Bis heute 15 Jahre und 9 Monate, seit Okt. 2008

    Manager

    Biosciences Inc

  • 2 Jahre und 11 Monate, Apr. 2006 - Feb. 2009

    Senior Scientist

    Erimos Pharmaceuticals

    • Major responsibilities – directing and managing research projects related to medicinal chemistry, including design and synthesis of biologically active target analogs and libraries, hit discovery and lead optimization. • Process development for terameprocol, nordihydroguaiaretic acid (NDGA) and other NDGA-related NCEs. • Other duties including: (1) synthesis of radiolabeled drug API. (2) supporting pre-formulation test and ADMET study.

  • 1 Jahr und 6 Monate, Nov. 2004 - Apr. 2006

    Senior Scientist

    MedTox Diagnostics Inc.

    • Project managers for process development, contract manufacturing of small drug molecules (over 20 small molecule drugs, drug metabolites were manufactured, which were used in MedTox’s Profile-II® series drug screen devices). • Team leader to develop Profile III-Alco® device, a test strip which can rapidly determine alcohol in saliva.

  • 3 Jahre und 11 Monate, Okt. 2000 - Aug. 2004

    Associate Director of Medicinal Chemistry

    BioMarin Pharmaceutical Inc.

    • Synthesized small molecule drug candidates, which structures are related to doxorubicin, taxol, camptothecin. Developed new methods for the synthesis of small molecule bioconjugates targeted brain tumors. • Participated in research programs of Laronidase (for MPS I disease, FDA approved in 2002), and NeuroTransTM (CNS diseases, preclinical candidates in 2002 - 2004).

Ausbildung von Qingqi Chen

  • 2 Jahre und 1 Monat, Okt. 1998 - Okt. 2000

    Synthetic/Medicinal Chemistry

    The University of British Columbia

    design, synthesis and evaluation, screening and lead optimization of small molecule drugs.

  • 3 Jahre und 1 Monat, Okt. 1995 - Okt. 1998

    Synthetetic Chemistry

    University of Nevada Reno

    design, synthesis and evaluation, screening and lead optimization of small molecule drugs.

  • 1 Jahr und 8 Monate, Dez. 1993 - Juli 1995

    Synthetic Chemistry

    Johannes-Kepler University Linz

    design, synthesis and evaluation, screening and lead optimization of small molecule drugs.

  • 3 Jahre und 1 Monat, Juli 1990 - Juli 1993

    Synthetic Chemistry

    Peking University

    Total synthesis of natural products

Sprachen

  • Englisch

    Fließend

  • Chinesisch

    Muttersprache

Interessen

synthetic chemistry
Contract research organization
small molecule drug discovery

21 Mio. XING Mitglieder, von A bis Z